User Manual Part 3

7-4
PATIENT DIAGNOSTICS
TRENDS
HRV Footprint––displays the percentage of the graph area used by the
HRV plot. The graph area portrays a n “at-a-glance snapshot” of the
distribution of variability versus heart ra te over a 24-hour period. T h e
trended percentage is a normalized score based on the footprint in the
graph. If an HRV plot was not obtained for the 24-hour period, then the
HRV Footprint is not calculated and a value of “N/R” is displayed.
ABM (Autonomic Balance Monitor)––a device calculation based on
R–R int erval mea surements; it mathe matically functions as a surroga te
measurement for LF/HF ratio.
1
Intervalsusedinthecalculationmustbe
valid sinus rhythm intervals as determin ed b y the HRV collection criteria. If
the H RV data is invalid for the 24-hour collection period, then the ABM is
not calculated for that collection period and a value of "N/R" is displayed.
Amplitude––provides amplitude measurements
Impedance––provides impedance measurements
Follow the steps below to access Trends:
1. From the Events screen, select the Trends Tab
2. Choose the Select Trends button to specify the trends you want to view.
You can choose from the following categories:
Heart Failure––includes Heart Rate, SDANN, and HRV Footprint trends
Atrial Arrhythmia––includes Events, Heart Rate, and Atrial Burden
trends
Activity––includes Heart Rate, Activity Level, and Respiratory Rate
trends
Custom –– allows you to select three tre nds t o custo mize t he information
displayed on the Trends screen
Thedisplayonthescreencanbeviewedinthefollowingmanners:
Select the desired time on the View button to choose the length of visible
trend data.
1. Parasympathetic tone is prim arily reected in the high-frequency ( HF) component of
s
pectral analysis. The low-frequency (LF) component is inuenced by both the sympathetic
and parasympathetic nervous systems. The LF/HF ratio is c onsidered a measure of
sympathovagal balance and reects sympathetic modulations. (Source: A CC/AHA Guidelines
for Ambulatory Electrocardiography—Part III, JACC VOL. 34, No. 3, September 1999:912–48)
- DRAFT -